Teva Pharma (TEVA), Active Biotech Discontinue Higher Doses of Laquinimod in Two MS Trials After CS Events
Tweet Send to a Friend
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Active Biotech announced the discontinuation of higher doses of laquinimod in two ongoing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
